StockNews.com Upgrades LivaNova (NASDAQ:LIVN) to Strong-Buy

LivaNova (NASDAQ:LIVN) was upgraded by investment analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Tuesday.

A number of other research analysts have also issued reports on the stock. Needham & Company LLC reiterated a “buy” rating and issued a $64.00 price objective on shares of LivaNova in a report on Monday, March 17th. Wolfe Research cut shares of LivaNova from an “outperform” rating to a “peer perform” rating in a research note on Wednesday, February 26th. The Goldman Sachs Group lowered their target price on LivaNova from $64.00 to $55.00 and set a “buy” rating for the company in a research report on Monday, March 3rd. Barclays reduced their price target on LivaNova from $58.00 to $56.00 and set an “equal weight” rating on the stock in a research report on Friday, March 7th. Finally, Mizuho lowered their price objective on LivaNova from $70.00 to $60.00 and set an “outperform” rating for the company in a research report on Wednesday, February 26th. Two analysts have rated the stock with a hold rating, five have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $61.17.

LivaNova Stock Down 0.1 %

Shares of LIVN opened at $39.90 on Tuesday. The stock has a market capitalization of $2.17 billion, a price-to-earnings ratio of 95.00 and a beta of 1.10. LivaNova has a 52 week low of $36.85 and a 52 week high of $64.48. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.87 and a current ratio of 3.37. The stock has a fifty day moving average of $44.86 and a 200-day moving average of $48.58.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in LIVN. Russell Investments Group Ltd. grew its stake in LivaNova by 17.1% during the fourth quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company’s stock worth $70,000 after purchasing an additional 219 shares during the period. Sterling Capital Management LLC boosted its holdings in shares of LivaNova by 800.6% during the 4th quarter. Sterling Capital Management LLC now owns 1,621 shares of the company’s stock worth $75,000 after buying an additional 1,441 shares in the last quarter. Central Pacific Bank Trust Division grew its position in shares of LivaNova by 21.2% during the 4th quarter. Central Pacific Bank Trust Division now owns 4,117 shares of the company’s stock worth $191,000 after buying an additional 720 shares during the period. Vestcor Inc bought a new stake in shares of LivaNova in the 4th quarter valued at $204,000. Finally, Optimize Financial Inc acquired a new position in shares of LivaNova during the 4th quarter valued at $208,000. 97.64% of the stock is owned by institutional investors.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.